Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate 35573-0468-02
- Manufacturer
- Burel Pharmaceuticals, Llc
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- December 16, 2019
- Application
- ANDA212037
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 6.25 mg/1 |
| Amphetamine Sulfate | 6.25 mg/1 |
| Dextroamphetamine Saccharate | 6.25 mg/1 |
| Dextroamphetamine Sulfate | 6.25 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Selected Package
35573-0468-02Selected100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (35573-468-02)